Jasper Stevens

About Jasper Stevens

Jasper Stevens, With an exceptional h-index of 16 and a recent h-index of 14 (since 2020), a distinguished researcher at Rijksuniversiteit Groningen, specializes in the field of Diabetes and PKPD modeling.

His recent articles reflect a diverse array of research interests and contributions to the field:

JAnSafety, tolerability and toxicokinetics of the novel mitochondrial drug SUL-138 administered orally to rat and minipig

Global estimates and determinants of antituberculosis drug pharmacokinetics in children and adolescents: a systematic review and individual patient data meta-analysis

Sex-based differences in nuclear medicine imaging and therapy

Glycemic Control and Effects of Canagliflozin in Reducing Albuminuria and eGFR: A: Post Hoc: Analysis of the CREDENCE Trial

Feasibility Study to Assess Canagliflozin Distribution and Sodium‐Glucose Co‐Transporter 2 Occupancy Using [18F]Canagliflozin in Patients with Type 2 Diabetes

Exposure–Response Analysis of the Sodium–Glucose Cotransporter-2 Inhibitors Dapagliflozin and Empagliflozin on Kidney Hemodynamics in Patients with Type 2 Diabetes

Bedaquiline exposure in people with drug-resistant TB treated for diabetes: analysis of two phase 2 trials

Studying Telmisartan Plasma Exposure, Kidney Distribution, Receptor Occupancy, and Response in Patients With Type 2 Diabetes Using [11C]Telmisartan

Jasper Stevens Information

University

Position

Researcher, University Medical Center Groningen, department of Clinical Pharmacy and Pharmacology

Citations(all)

857

Citations(since 2020)

617

Cited By

505

hIndex(all)

16

hIndex(since 2020)

14

i10Index(all)

26

i10Index(since 2020)

21

Email

University Profile Page

Google Scholar

Jasper Stevens Skills & Research Interests

Diabetes and PKPD modeling

Top articles of Jasper Stevens

JAnSafety, tolerability and toxicokinetics of the novel mitochondrial drug SUL-138 administered orally to rat and minipig

Toxicology Reports

2024/3/19

Jasper Stevens
Jasper Stevens

H-Index: 11

Global estimates and determinants of antituberculosis drug pharmacokinetics in children and adolescents: a systematic review and individual patient data meta-analysis

2023/3/1

Sex-based differences in nuclear medicine imaging and therapy

European journal of nuclear medicine and molecular imaging

2023/3

Glycemic Control and Effects of Canagliflozin in Reducing Albuminuria and eGFR: A: Post Hoc: Analysis of the CREDENCE Trial

Clinical Journal of the American Society of Nephrology

2023/6/1

Niels Jongs
Niels Jongs

H-Index: 3

Jasper Stevens
Jasper Stevens

H-Index: 11

Feasibility Study to Assess Canagliflozin Distribution and Sodium‐Glucose Co‐Transporter 2 Occupancy Using [18F]Canagliflozin in Patients with Type 2 Diabetes

Clinical Pharmacology & Therapeutics

2023/6

Jasper Stevens
Jasper Stevens

H-Index: 11

Exposure–Response Analysis of the Sodium–Glucose Cotransporter-2 Inhibitors Dapagliflozin and Empagliflozin on Kidney Hemodynamics in Patients with Type 2 Diabetes

Journal of personalized medicine

2023/4/27

Jasper Stevens
Jasper Stevens

H-Index: 11

Bedaquiline exposure in people with drug-resistant TB treated for diabetes: analysis of two phase 2 trials

The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease

2023/4/1

Studying Telmisartan Plasma Exposure, Kidney Distribution, Receptor Occupancy, and Response in Patients With Type 2 Diabetes Using [11C]Telmisartan

Clinical Pharmacology & Therapeutics

2022/12

Jasper Stevens
Jasper Stevens

H-Index: 11

Treatment Outcomes of Childhood Tuberculous Meningitis in a Real-World Retrospective Cohort, Bandung, Indonesia

Emerging Infectious Diseases

2022/3

Current use and complementary value of combining in vivo imaging modalities to understand the Renoprotective effects of sodium-glucose Cotransporter-2 inhibitors at a tissue level

2022/2/21

Jasper Stevens
Jasper Stevens

H-Index: 11

Kinetics of copeptin, surrogate marker for vasopressin

Vasopressin and copeptin

2022

Jasper Stevens
Jasper Stevens

H-Index: 11

GMP Compliant Synthesis of [18F]Canagliflozin, a Novel PET Tracer for the Sodium–Glucose Cotransporter 2

Journal of Medicinal Chemistry

2021/11/8

Jasper Stevens
Jasper Stevens

H-Index: 11

Safety, pharmacokinetics and pharmacodynamics of HTL0009936, a selective muscarinic M1‐acetylcholine receptor agonist: A randomized cross‐over trial

British Journal of Clinical Pharmacology

2021/11

Jasper Stevens
Jasper Stevens

H-Index: 11

Simplified Iohexol-Based Method for Measurement of Glomerular Filtration Rate in Goats and Pigs

Biology

2021/5/23

Jasper Stevens
Jasper Stevens

H-Index: 11

The power of modelling pulsatile profiles

Journal of pharmacokinetics and pharmacodynamics

2021/6

Jasper Stevens
Jasper Stevens

H-Index: 11

Individual atrasentan exposure is associated with long‐term kidney and heart failure outcomes in patients with type 2 diabetes and chronic kidney disease

Clinical Pharmacology & Therapeutics

2021/6

L and Mol PGM (2021) A Review of the Dose Justification of Phase 3 Trials to Regulatory Authorities for Drugs Intended for the Treatment of Type 2 Diabetes in Europe

2021/4/28

A review of the dose justification of phase 3 trials to regulatory authorities for drugs intended for the treatment of type 2 diabetes in Europe

2021/4/28

Jasper Stevens
Jasper Stevens

H-Index: 11

Evaluation of the Pharmacokinetics and Exposure–Response Relationship of Dapagliflozin in Patients without Diabetes and with Chronic Kidney Disease

Clinical pharmacokinetics

2021/4

Inter‐individual variability in atrasentan exposure partly explains variability in kidney protection and fluid retention responses: A post hoc analysis of the SONAR trial

Diabetes, Obesity and Metabolism

2021/2

See List of Professors in Jasper Stevens University(Rijksuniversiteit Groningen)